• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Substrate-Dependent Modulation of SIRT2 by a Fluorescent Probe, 1-Aminoanthracene.荧光探针 1-氨基蒽对 SIRT2 的底物依赖性调节。
Biochemistry. 2020 Oct 13;59(40):3869-3878. doi: 10.1021/acs.biochem.0c00564. Epub 2020 Sep 29.
2
A homogeneous time-resolved fluorescence screen to identify SIRT2 deacetylase and defatty-acylase inhibitors.一种均相时间分辨荧光屏,用于鉴定 SIRT2 脱乙酰酶和脱脂酶抑制剂。
PLoS One. 2024 Jun 24;19(6):e0305000. doi: 10.1371/journal.pone.0305000. eCollection 2024.
3
Chemical Probes Reveal Sirt2's New Function as a Robust "Eraser" of Lysine Lipoylation.化学探针揭示 Sirt2 作为赖氨酸脂酰化的强有力“橡皮擦”的新功能。
J Am Chem Soc. 2019 Nov 20;141(46):18428-18436. doi: 10.1021/jacs.9b06913. Epub 2019 Nov 7.
4
High-Throughput Screening Identifies Ascorbyl Palmitate as a SIRT2 Deacetylase and Defatty-Acylase Inhibitor.高通量筛选鉴定抗坏血酸棕榈酸酯为 SIRT2 脱乙酰酶和脱脂酶抑制剂。
ChemMedChem. 2021 Nov 19;16(22):3484-3494. doi: 10.1002/cmdc.202100343. Epub 2021 Sep 2.
5
Sirtuin 2 mutations in human cancers impair its function in genome maintenance.人类癌症中的沉默调节蛋白2突变会损害其在基因组维持中的功能。
J Biol Chem. 2017 Jun 16;292(24):9919-9931. doi: 10.1074/jbc.M116.772566. Epub 2017 May 1.
6
Protocols for Cloning, Expression, and Functional Analysis of Sirtuin2 (SIRT2).沉默调节蛋白2(SIRT2)的克隆、表达及功能分析实验方案
Methods Mol Biol. 2016;1436:189-99. doi: 10.1007/978-1-4939-3667-0_13.
7
Effects of Dimerization on the Deacylase Activities of Human SIRT2.二聚化对人源 SIRT2 的去酰基酶活性的影响。
Biochemistry. 2023 Dec 5;62(23):3383-3395. doi: 10.1021/acs.biochem.3c00381. Epub 2023 Nov 15.
8
Propofol inhibits SIRT2 deacetylase through a conformation-specific, allosteric site.丙泊酚通过一个构象特异性的变构位点抑制SIRT2去乙酰化酶。
J Biol Chem. 2015 Mar 27;290(13):8559-68. doi: 10.1074/jbc.M114.620732. Epub 2015 Feb 9.
9
Efficient demyristoylase activity of SIRT2 revealed by kinetic and structural studies.动力学和结构研究揭示SIRT2高效的去肉豆蔻酰化酶活性
Sci Rep. 2015 Feb 23;5:8529. doi: 10.1038/srep08529.
10
Sirt2 Regulates Liver Metabolism in a Sex-Specific Manner.Sirt2 以性别特异性方式调节肝脏代谢。
Biomolecules. 2024 Sep 15;14(9):1160. doi: 10.3390/biom14091160.

引用本文的文献

1
Structural basis for sirtuin 2 activity and modulation: Current state and opportunities.沉默调节蛋白2的活性与调控的结构基础:现状与机遇
J Biol Chem. 2025 May 22;301(7):110274. doi: 10.1016/j.jbc.2025.110274.
2
Ion-DNA Interactions as a Key Determinant of Uracil DNA Glycosylase Activity.离子与DNA的相互作用是尿嘧啶DNA糖基化酶活性的关键决定因素。
Biochemistry. 2025 May 20;64(10):2332-2344. doi: 10.1021/acs.biochem.5c00067. Epub 2025 May 7.
3
A homogeneous time-resolved fluorescence screen to identify SIRT2 deacetylase and defatty-acylase inhibitors.一种均相时间分辨荧光屏,用于鉴定 SIRT2 脱乙酰酶和脱脂酶抑制剂。
PLoS One. 2024 Jun 24;19(6):e0305000. doi: 10.1371/journal.pone.0305000. eCollection 2024.
4
Effects of Dimerization on the Deacylase Activities of Human SIRT2.二聚化对人源 SIRT2 的去酰基酶活性的影响。
Biochemistry. 2023 Dec 5;62(23):3383-3395. doi: 10.1021/acs.biochem.3c00381. Epub 2023 Nov 15.
5
In silico drug discovery of SIRT2 inhibitors from natural source as anticancer agents.从天然来源中筛选 SIRT2 抑制剂的计算机药物发现作为抗癌药物。
Sci Rep. 2023 Feb 7;13(1):2146. doi: 10.1038/s41598-023-28226-7.
6
Substrate-selective small-molecule modulators of enzymes: Mechanisms and opportunities.酶的底物选择性小分子调节剂:机制与机遇。
Curr Opin Chem Biol. 2023 Feb;72:102231. doi: 10.1016/j.cbpa.2022.102231. Epub 2022 Nov 28.
7
A Conserved Mechanism for Hormesis in Molecular Systems.分子系统中兴奋效应的一种保守机制。
Dose Response. 2022 Aug 2;20(3):15593258221109335. doi: 10.1177/15593258221109335. eCollection 2022 Jul-Sep.

本文引用的文献

1
Mechanism of activation for the sirtuin 6 protein deacylase.沉默调节蛋白6(Sirtuin 6)蛋白去乙酰化酶的激活机制。
J Biol Chem. 2020 Jan 31;295(5):1385-1399. doi: 10.1074/jbc.RA119.011285. Epub 2019 Dec 10.
2
Anesthetic preconditioning increases sirtuin 2 gene expression in a renal ischemia reperfusion injury model.在肾脏缺血再灌注损伤模型中,麻醉预处理可增加沉默信息调节因子2基因的表达。
Minerva Urol Nefrol. 2020 Apr;72(2):243-249. doi: 10.23736/S0393-2249.19.03361-7. Epub 2019 Nov 11.
3
A Glycoconjugated SIRT2 Inhibitor with Aqueous Solubility Allows Structure-Based Design of SIRT2 Inhibitors.一种具有水溶性的糖缀合 SIRT2 抑制剂,可实现基于结构的 SIRT2 抑制剂设计。
ACS Chem Biol. 2019 Aug 16;14(8):1802-1810. doi: 10.1021/acschembio.9b00384. Epub 2019 Aug 2.
4
Development of Peptide-Based Sirtuin Defatty-Acylase Inhibitors Identified by the Fluorescence Probe, SFP3, That Can Efficiently Measure Defatty-Acylase Activity of Sirtuin.基于荧光探针 SFP3 的 Sirtuin 脱酰酶抑制剂的开发,该探针可高效测量 Sirtuin 的脱酰酶活性。
J Med Chem. 2019 Jun 13;62(11):5434-5452. doi: 10.1021/acs.jmedchem.9b00315. Epub 2019 May 30.
5
Direct Comparison of SIRT2 Inhibitors: Potency, Specificity, Activity-Dependent Inhibition, and On-Target Anticancer Activities.SIRT2 抑制剂的直接比较:效力、特异性、活性依赖性抑制和靶向抗癌活性。
ChemMedChem. 2018 Sep 19;13(18):1890-1894. doi: 10.1002/cmdc.201800391. Epub 2018 Aug 13.
6
Identification of a novel small molecule that inhibits deacetylase but not defatty-acylase reaction catalysed by SIRT2.鉴定一种新型小分子,该小分子抑制去乙酰化酶,但不抑制 SIRT2 催化的脱脂酰基酶反应。
Philos Trans R Soc Lond B Biol Sci. 2018 Jun 5;373(1748). doi: 10.1098/rstb.2017.0070.
7
Recent progress on the molecular pharmacology of propofol.丙泊酚分子药理学的最新进展
F1000Res. 2018 Jan 29;7:123. doi: 10.12688/f1000research.12502.1. eCollection 2018.
8
SIRT2 and lysine fatty acylation regulate the transforming activity of K-Ras4a.SIRT2 和赖氨酸脂肪酸酰化调节 K-Ras4a 的转化活性。
Elife. 2017 Dec 14;6:e32436. doi: 10.7554/eLife.32436.
9
Investigation of N-Terminal Phospho-Regulation of Uracil DNA Glycosylase Using Protein Semisynthesis.利用蛋白质半合成法对尿嘧啶DNA糖基化酶N端磷酸化调控的研究
Biophys J. 2017 Jul 25;113(2):393-401. doi: 10.1016/j.bpj.2017.06.016.
10
SIRT2 Reverses 4-Oxononanoyl Lysine Modification on Histones.SIRT2可逆转组蛋白上的4-氧代壬酰赖氨酸修饰。
J Am Chem Soc. 2016 Sep 28;138(38):12304-7. doi: 10.1021/jacs.6b04977. Epub 2016 Sep 15.

荧光探针 1-氨基蒽对 SIRT2 的底物依赖性调节。

Substrate-Dependent Modulation of SIRT2 by a Fluorescent Probe, 1-Aminoanthracene.

机构信息

Department of Molecular Biology, Rowan University School of Osteopathic Medicine, Stratford, New Jersey 08084, United States.

Department of Chemistry and Chemical Biology, Cornell University, Ithaca, New York 14853, United States.

出版信息

Biochemistry. 2020 Oct 13;59(40):3869-3878. doi: 10.1021/acs.biochem.0c00564. Epub 2020 Sep 29.

DOI:10.1021/acs.biochem.0c00564
PMID:32941003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7880049/
Abstract

Sirtuin isoform 2 (SIRT2) is an enzyme that catalyzes the removal of acyl groups from lysine residues. SIRT2's catalytic domain has a hydrophobic tunnel where its substrate acyl groups bind. Here, we report that the fluorescent probe 1-aminoanthracene (AMA) binds within SIRT2's hydrophobic tunnel in a substrate-dependent manner. AMA's interaction with SIRT2 was characterized by its enhanced fluorescence upon protein binding (>10-fold). AMA interacted weakly with SIRT2 alone in solution ( = 37 μM). However, when SIRT2 was equilibrated with a decanoylated peptide substrate, AMA's affinity for SIRT2 was enhanced ∼10-fold ( = 4 μM). The peptide's decanoyl chain and AMA co-occupied SIRT2's hydrophobic tunnel when bound to the protein. In contrast, binding of AMA to SIRT2 was competitive with a myristoylated substrate whose longer acyl chain occluded the entire tunnel. AMA competitively inhibited SIRT2 demyristoylase activity with an IC of 21 μM, which was significantly more potent than its inhibition of other deacylase activities. Finally, binding and structural analysis suggests that the AMA binding site in SIRT2's hydrophobic tunnel was structurally stabilized when SIRT2 interacted with a decanoylated or 4-oxononanoylated substrate, but AMA's binding site was less stable when SIRT2 was bound to an acetylated substrate. Our use of AMA to explore changes in SIRT2's hydrophobic tunnel that are induced by interactions with specific acylated substrates has implications for developing ligands that modulate SIRT2's substrate specificity.

摘要

Sirtuin 同种型 2(SIRT2)是一种催化赖氨酸残基上酰基去除的酶。SIRT2 的催化结构域有一个疏水性隧道,其底物酰基结合在其中。在这里,我们报告荧光探针 1-氨基蒽(AMA)以底物依赖的方式结合在 SIRT2 的疏水性隧道内。AMA 与 SIRT2 的相互作用通过其与蛋白质结合时增强的荧光(>10 倍)来表征。AMA 单独在溶液中与 SIRT2 弱相互作用(=37 μM)。然而,当 SIRT2 与去癸酰化肽底物平衡时,AMA 与 SIRT2 的亲和力增强了约 10 倍(=4 μM)。当结合到蛋白质时,肽的癸酰链和 AMA 共同占据 SIRT2 的疏水性隧道。相比之下,AMA 与 SIRT2 的结合是竞争性的,与具有较长酰基链的豆蔻酰化底物竞争,其占据整个隧道。AMA 竞争性地抑制 SIRT2 的脱豆蔻酰酶活性,IC 为 21 μM,其抑制作用明显强于其他脱酰酶活性。最后,结合和结构分析表明,当 SIRT2 与去癸酰化或 4-氧代壬酰化底物相互作用时,AMA 在 SIRT2 的疏水性隧道中的结合位点在结构上得到稳定,但当 SIRT2 与乙酰化底物结合时,AMA 的结合位点稳定性降低。我们使用 AMA 来探索与特定酰化底物相互作用引起的 SIRT2 疏水性隧道的变化,这对于开发调节 SIRT2 底物特异性的配体具有重要意义。